Table 2.
Parameter | Mean ± SD N (%) |
---|---|
Protocol parameters | |
FDG dose (mCi) | 9.1 ± 0.8 |
Time to imaging following FDG injection (min) | 59 ± 13 |
Diet adherence | 111 (100%) |
Heparin administration | 111 (100%) |
Adequate myocardial suppression | 106 (95.5%) |
Metabolic parameters | |
Fasting glucose (mg/dL) | 100.9 ± 39.6 |
Glucose baseline Pre-FDG injection (mg/dL) | 97.1 ± 36.5 |
Glucose post-UFH (mg/dL) | 96.2 ± 37.1 |
C-peptide baseline Pre-FDG injection (ng/mL) | 2.9 ± 2.5 |
C-peptide post-UFH (ng/mL) | 2.8 ± 2.5 |
Insulin level baseline Pre-FDG (μU/mL) | 12.8 ± 13.4 |
Insulin level post-UFH (μU/mL) | 12.5 ± 13.3 |
FFA fasting (mmol/L) | 0.74 ± 0.33 |
FFA post-test meal drink/pre-UFH/pre-FDG injection (mmol/L) | 0.87 ± 0.32 |
FFA post-UFH (mmol/L) | 1.48 ± 0.90 |
TG fasting (mg/dL) | 154.7 ± 199.6 |
TG post-test meal drink/pre-UFH/Pre-FDG injection (mg/dL) | 159.5 ± 178.8 |
TG post-UFH (mg/dL) | 113.8 ± 178.4 |
Background FDG activity aorta (SUVmean) | 2.1 ± 0.4 |
Myocardial FDG activity mid-septal wall (SUVmax)a | 1.8 ± 1.0 |
Myocardial FDG activity mid-lateral wall (SUVmax)a | 1.8 ± 1.3 |
Denotes SUVmax in ROI measuring normal myocardium